Cargando…
A Timely CIBMTR Analysis of How Cryopreservation Impacts Allogeneic Hematopoietic Cell Transplantation to Apply in the COVID Era
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc. on behalf of The American Society for Transplantation and Cellular Therapy.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205308/ https://www.ncbi.nlm.nih.gov/pubmed/34144791 http://dx.doi.org/10.1016/j.jtct.2021.05.009 |
| _version_ | 1783708482870968320 |
|---|---|
| author | Allan, David S. |
| author_facet | Allan, David S. |
| author_sort | Allan, David S. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8205308 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Published by Elsevier Inc. on behalf of The American Society for Transplantation and Cellular Therapy. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82053082021-06-16 A Timely CIBMTR Analysis of How Cryopreservation Impacts Allogeneic Hematopoietic Cell Transplantation to Apply in the COVID Era Allan, David S. Transplant Cell Ther The Bottom Line Published by Elsevier Inc. on behalf of The American Society for Transplantation and Cellular Therapy. 2021-06 2021-06-15 /pmc/articles/PMC8205308/ /pubmed/34144791 http://dx.doi.org/10.1016/j.jtct.2021.05.009 Text en © 2019 Published by Elsevier Inc. on behalf of The American Society for Transplantation and Cellular Therapy. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | The Bottom Line Allan, David S. A Timely CIBMTR Analysis of How Cryopreservation Impacts Allogeneic Hematopoietic Cell Transplantation to Apply in the COVID Era |
| title | A Timely CIBMTR Analysis of How Cryopreservation Impacts Allogeneic Hematopoietic Cell Transplantation to Apply in the COVID Era |
| title_full | A Timely CIBMTR Analysis of How Cryopreservation Impacts Allogeneic Hematopoietic Cell Transplantation to Apply in the COVID Era |
| title_fullStr | A Timely CIBMTR Analysis of How Cryopreservation Impacts Allogeneic Hematopoietic Cell Transplantation to Apply in the COVID Era |
| title_full_unstemmed | A Timely CIBMTR Analysis of How Cryopreservation Impacts Allogeneic Hematopoietic Cell Transplantation to Apply in the COVID Era |
| title_short | A Timely CIBMTR Analysis of How Cryopreservation Impacts Allogeneic Hematopoietic Cell Transplantation to Apply in the COVID Era |
| title_sort | timely cibmtr analysis of how cryopreservation impacts allogeneic hematopoietic cell transplantation to apply in the covid era |
| topic | The Bottom Line |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205308/ https://www.ncbi.nlm.nih.gov/pubmed/34144791 http://dx.doi.org/10.1016/j.jtct.2021.05.009 |
| work_keys_str_mv | AT allandavids atimelycibmtranalysisofhowcryopreservationimpactsallogeneichematopoieticcelltransplantationtoapplyinthecovidera AT allandavids timelycibmtranalysisofhowcryopreservationimpactsallogeneichematopoieticcelltransplantationtoapplyinthecovidera |